News

Mosquitos can easily and efficiently transmit this virus to humans causing high fever, severe muscle/joint pain, headache, fatigue and rash. While there is currently no FDA-approved vaccine to

The administration of particulate matter, if present in an intravenous drug, poses a potential safety risk to patients such as a thromboembolism or a life-threatening pulmonary embolism. Other

Under the agreement, Fred’s and Cardinal Health will establish a mutually beneficial strategic alliance designed to support Fred’s key initiative of rapid pharmacy growth, and build on a

The approval follows after a request from the Liberian Government on 8 August to send sample doses of experimental Serum for use on two Liberian doctors who are

The fresh round of charges was said to be seen by Reuters news agency in an anonymous email sent to chief executive Andrew Witty and GSK audit committee

Conducted on 15 healthy volunteers at Linear Clinical Research’s facility in Perth, Australia, the study validated additional pharmacokinetic parameters associated with the safety and elimination profile that remained

The retinal device will be offered to late-stage retinitis pigmentosa (RP) patients in six German university clinics and teaching hospitals. Retina Implant CEO Walter-G Wrobel said: "Since receiving

Sanofi and Mannkind have signed an exclusive licensing agreement to develop and market the latter’s inhaled insulin diabetes therapy Afrezza. Under the terms of the agreement, France-based Sanofi

The Economic Times has reported that the drug company is likely to introduce its generic drugs in Japan in three to four years after the deal with Ranbaxy